Research Topic: Medicinal

Cytotoxic activity of Ganoderma weberianum-sichuanese isolated from the Lower Volta River Basin of Ghana against human prostate carcinoma (PC-3), leukemic T cell (Jurkat), and plasmacytoid dendritic cell (pDC)-derived acute leukemia (PMDC05) cell lines

mycolabadmin

Researchers tested a fungus called Ganoderma weberianum-sichuanese from Ghana’s Lower Volta River to see if it could kill cancer cells. They found that extracts from this fungus could effectively suppress the growth of three types of human cancer cells—prostate cancer, T-cell leukemia, and a rare dendritic cell leukemia—without harming normal liver cells. The most promising components were found in certain fractions of the extract, suggesting this natural fungus could potentially be developed into new cancer treatments.

Read More »

The role of Npt1 in regulating antifungal protein activity in filamentous fungi

mycolabadmin

Researchers discovered how antifungal proteins work against a dangerous fungus (Aspergillus flavus) that damages crops and produces toxins. They found that these proteins break down the fungal cell wall and then interact with an internal fungal protein called Ntp1. By understanding exactly which part of Ntp1 the antifungal proteins bind to, scientists can now develop better treatments to protect food crops from fungal diseases.

Read More »

The Ptk2-Pma1 pathway enhances tolerance to terbinafine in Trichophyton rubrum

mycolabadmin

Researchers discovered that a protein called TrPtk2 helps dermatophytes resist terbinafine, a common antifungal medicine. They found that blocking this protein makes the fungus more susceptible to terbinafine. Additionally, they discovered that omeprazole, a stomach medication approved for human use, can be combined with terbinafine to make it more effective against resistant fungal infections.

Read More »

When Emerging Fungal Infections Mimic Tuberculosis: First Reported Case of Invasive Emergomyces europaeus Infection in a Man With Immunocompromise Living in France

mycolabadmin

A 65-year-old man living in France who received a kidney transplant developed a serious fungal infection caused by Emergomyces europaeus, a rare fungus that initially appeared to be tuberculosis. Doctors used advanced genetic testing to identify the unusual fungus in samples from his lungs and bone marrow. The patient was treated with a combination of antifungal medications, which successfully cleared the infection. This is the first time this particular fungal infection has been documented in France and highlights how emerging infections can mimic more common diseases.

Read More »
Scroll to Top